BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38397248)

  • 1. Optimization of HIV Sequencing Method Using Vela Sentosa Library on Miseq Ilumina Platform.
    Papa Mze N; Fernand-Laurent C; Daugabel S; Zanzouri O; Marque Juillet S
    Genes (Basel); 2024 Feb; 15(2):. PubMed ID: 38397248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 genotypic resistance testing using the Vela automated next-generation sequencing platform.
    Raymond S; Nicot F; Carcenac R; Lefebvre C; Jeanne N; Saune K; Delobel P; Izopet J
    J Antimicrob Chemother; 2018 May; 73(5):1152-1157. PubMed ID: 29444253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of different massive parallel sequencing platforms for mutation profiling in formalin-fixed and paraffin-embedded samples].
    Jiang RR; Wang YJ; Teng XD; Xiao L; Bu H; Ye F
    Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):591-596. PubMed ID: 30107663
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of Illumina MiSeq and the Ion Torrent PGM and S5 platforms for whole-genome sequencing of picornaviruses and caliciviruses.
    Marine RL; Magaña LC; Castro CJ; Zhao K; Montmayeur AM; Schmidt A; Diez-Valcarce M; Ng TFF; Vinjé J; Burns CC; Nix WA; Rota PA; Oberste MS
    J Virol Methods; 2020 Jun; 280():113865. PubMed ID: 32302601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical Assessment of the Vela Diagnostics NGS Assay for HIV Genotyping and Resistance Testing: The Apulian Experience.
    Bonifacio MA; Genchi C; Lagioia A; Talamo V; Volpe A; Mariggiò MA
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective Evaluation of the Vela Diagnostics Next-Generation Sequencing Platform for HIV-1 Genotypic Resistance Testing.
    Weber J; Volkova I; Sahoo MK; Tzou PL; Shafer RW; Pinsky BA
    J Mol Diagn; 2019 Nov; 21(6):961-970. PubMed ID: 31382033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance evaluation of the Vela Dx Sentosa next-generation sequencing system for HIV-1 DNA genotypic resistance.
    Raymond S; Nicot F; Abravanel F; Minier L; Carcenac R; Lefebvre C; Harter A; Martin-Blondel G; Delobel P; Izopet J
    J Clin Virol; 2020 Jan; 122():104229. PubMed ID: 31809945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next generation sequencing improves detection of drug resistance mutations in infants after PMTCT failure.
    Fisher RG; Smith DM; Murrell B; Slabbert R; Kirby BM; Edson C; Cotton MF; Haubrich RH; Kosakovsky Pond SL; Van Zyl GU
    J Clin Virol; 2015 Jan; 62():48-53. PubMed ID: 25542470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of targeted next-generation sequencing for Plasmodium falciparum drug resistance markers.
    Kunasol C; Dondorp AM; Batty EM; Nakhonsri V; Sinjanakhom P; Day NPJ; Imwong M
    Sci Rep; 2022 Apr; 12(1):5563. PubMed ID: 35365711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 drug resistance mutations detection and HIV-1 subtype G report by using next-generation sequencing platform.
    Gholami M; Rouzbahani N; Samiee S; Tayeri K; Ghorban K; Dehkharghani AD; Gholami AA; Moshiri F; Sattari A; Dadmanesh M; Mohraz M
    Microb Pathog; 2020 Sep; 146():104221. PubMed ID: 32360523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine drug resistance testing in HIV-1 proviral DNA, using an automated next- generation sequencing assay.
    Alidjinou EK; Coulon P; Hallaert C; Robineau O; Meybeck A; Huleux T; Ajana F; Hober D; Bocket L
    J Clin Virol; 2019 Dec; 121():104207. PubMed ID: 31707202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the genetic diversity of influenza A viruses using next-generation DNA sequencing.
    Van den Hoecke S; Verhelst J; Vuylsteke M; Saelens X
    BMC Genomics; 2015 Feb; 16(1):79. PubMed ID: 25758772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards allele-level human leucocyte antigens genotyping - assessing two next-generation sequencing platforms: Ion Torrent Personal Genome Machine and Illumina MiSeq.
    Duke JL; Lind C; Mackiewicz K; Ferriola D; Papazoglou A; Derbeneva O; Wallace D; Monos DS
    Int J Immunogenet; 2015 Oct; 42(5):346-58. PubMed ID: 26119888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards clinical molecular diagnosis of inherited cardiac conditions: a comparison of bench-top genome DNA sequencers.
    Li X; Buckton AJ; Wilkinson SL; John S; Walsh R; Novotny T; Valaskova I; Gupta M; Game L; Barton PJ; Cook SA; Ware JS
    PLoS One; 2013; 8(7):e67744. PubMed ID: 23861798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of a Next-Generation Sequencing Assay for BRCA1 and BRCA2 Variants for the Clinical Laboratory.
    Strom CM; Rivera S; Elzinga C; Angeloni T; Rosenthal SH; Goos-Root D; Siaw M; Platt J; Braastadt C; Cheng L; Ross D; Sun W
    PLoS One; 2015; 10(8):e0136419. PubMed ID: 26295337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-genome and targeted sequencing of drug-resistant Mycobacterium tuberculosis on the iSeq100 and MiSeq: A performance, ease-of-use, and cost evaluation.
    Colman RE; Mace A; Seifert M; Hetzel J; Mshaiel H; Suresh A; Lemmer D; Engelthaler DM; Catanzaro DG; Young AG; Denkinger CM; Rodwell TC
    PLoS Med; 2019 Apr; 16(4):e1002794. PubMed ID: 31039166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of Benchtop Next Generation Sequencing Platforms Ion Torrent PGM and MiSeq in Noninvasive Prenatal Testing for Chromosome 21 Trisomy and Testing of Impact of In Silico and Physical Size Selection on Its Analytical Performance.
    Minarik G; Repiska G; Hyblova M; Nagyova E; Soltys K; Budis J; Duris F; Sysak R; Gerykova Bujalkova M; Vlkova-Izrael B; Biro O; Nagy B; Szemes T
    PLoS One; 2015; 10(12):e0144811. PubMed ID: 26669558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of sequencing platforms and bioinformatics pipelines for compositional analysis of the gut microbiome.
    Allali I; Arnold JW; Roach J; Cadenas MB; Butz N; Hassan HM; Koci M; Ballou A; Mendoza M; Ali R; Azcarate-Peril MA
    BMC Microbiol; 2017 Sep; 17(1):194. PubMed ID: 28903732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers.
    Quail MA; Smith M; Coupland P; Otto TD; Harris SR; Connor TR; Bertoni A; Swerdlow HP; Gu Y
    BMC Genomics; 2012 Jul; 13():341. PubMed ID: 22827831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of three next-generation sequencing platforms for metagenomic sequencing and identification of pathogens in blood.
    Frey KG; Herrera-Galeano JE; Redden CL; Luu TV; Servetas SL; Mateczun AJ; Mokashi VP; Bishop-Lilly KA
    BMC Genomics; 2014 Feb; 15():96. PubMed ID: 24495417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.